<DOC>
	<DOCNO>NCT00723424</DOCNO>
	<brief_summary>The purpose study examine effect AZD5672 ( dose steady state ) pharmacokinetics digoxin ( single dose administration ) .</brief_summary>
	<brief_title>Drug Interaction Study - Effect AZD5672 Pharmacokinetics Digoxin</brief_title>
	<detailed_description />
	<mesh_term>N- ( 1- ( 3- ( 3,5-difluorophenyl ) -3- ( 4-methanesulfonylphenyl ) propyl ) piperidin-4-yl ) -N-ethyl-2- ( 4-methanesulfonylphenyl ) acetamide</mesh_term>
	<mesh_term>Digoxin</mesh_term>
	<criteria>Provision sign write informed consent . Females childbearing potential Clinically normal physical laboratory finding judge investigator , include negative drug test negative test Hepatitis B surface antigen , antibody Hepatitis C virus antibody HIV . Any clinically significant disease disorder , opinion investigator , may either put subject risk participation study , may influence result study , subject 's ability participate Known allergy digoxin previous complication digoxin therapy . Participation clinical study involve investigational product 3 month prior enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>AZD5672</keyword>
	<keyword>digoxin</keyword>
</DOC>